Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Verena, Zangen"'
Autor:
Marius Ueffing, Cédrik Schöne, Rupert Langer, Stefanie M. Hauck, Stefan Maier, Benjamin Balluff, Ludwig Hierber, Axel Walch, Stephan Meding, Marcus Feith, Michaela Aichler, Manfred Schmitt, Bernhard Kuster, Sandra Rauser, H. Braselmann, Horst Zitzelsberger, Heinz Höfler, Mareike Elsner, Michaela Aubele, Natalie Ludyga, Verena Zangen, Hans Zischka, Annette Feuchtinger
Publikováno v:
The Journal of Pathology. 230:410-419
Chemotherapeutic drugs kill cancer cells, but it is unclear why this happens in responding patients but not in non-responders. Proteomic profiles of patients with oesophageal adenocarcinoma may be helpful in predicting response and selecting more eff
Autor:
Verena Zangen, Martin Selmansberger, Guido A. Drexler, A. Michna, Sebastian Kuger, Julia Hess, Igor Gimenez-Aznar, Anna A. Friedl, Kristian Unger, Diana Klein, Ramona Stamp, Horst Zitzelsberger, Claus Belka, U. Schötz, Lars Schüttrumpf, Kirsten Lauber, Herbert Braselmann, Verena Jendrossek, Michael Orth, Ludmila Schneider, Ludwig Hieber
Publikováno v:
Cancer letters. 386
Radio (chemo) therapy is a crucial treatment modality for head and neck squamous cell carcinoma (HNSCC), but relapse is frequent, and the underlying mechanisms remain largely elusive. Therefore, novel biomarkers are urgently needed. Previously, we id
Autor:
Isolde Summerer, Maximilian Niyazi, Kristian Unger, Adriana Pitea, Verena Zangen, Julia Hess, Michael J Atkinson, Claus Belka, Simone Moertl, Horst Zitzelsberger
Publikováno v:
Radiat. Oncol. 10:102 (2015)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Circulating microRNAs (miRNAs) are easily accessible and have already proven to be useful as prognostic markers in cancer patients. However, their origin and function in the circulation is still under discussion. In the present study we analyzed chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02feefef60e3b654429be26f1f814586
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=44478
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=44478
Autor:
Kristian Unger, Simone Moertl, Isolde Summerer, Horst Zitzelsberger, Verena Zangen, Julia Hess, Michael J. Atkinson, Maximilian Niyazi, Adriana Pitea, Claus Belka
Publikováno v:
Radiat. Oncol. 8:296 (2013)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
NTRODUCTION: Circulating microRNAs (miRNAs) are easily accessible and have already proven to be useful as prognostic markers in cancer patients. However, their origin and function in the circulation is still under discussion. In the present study we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaada3dfd847578b8793dc0ceee3ae62
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=28904
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=28904
Autor:
Michaela, Aichler, Mareike, Elsner, Natalie, Ludyga, Annette, Feuchtinger, Verena, Zangen, Stefan K, Maier, Benjamin, Balluff, Cédrik, Schöne, Ludwig, Hierber, Herbert, Braselmann, Stephan, Meding, Sandra, Rauser, Hans, Zischka, Michaela, Aubele, Manfred, Schmitt, Marcus, Feith, Stefanie M, Hauck, Marius, Ueffing, Rupert, Langer, Bernhard, Kuster, Horst, Zitzelsberger, Heinz, Höfler, Axel K, Walch
Publikováno v:
The Journal of pathology. 230(4)
Chemotherapeutic drugs kill cancer cells, but it is unclear why this happens in responding patients but not in non-responders. Proteomic profiles of patients with oesophageal adenocarcinoma may be helpful in predicting response and selecting more eff